Women's Health

AHA: Caladrius single injection helps heart disease that hits women the hardest
AHA: Caladrius single injection helps heart disease that hits women the hardest
Fierce Biotech
Caladrius Biosciences
Women's Health
heart disease
AHA
CLBS16
Syndrome X
Flag link:
One health care startup at a time, this venture capitalist wants to harness the investing power of women
One health care startup at a time, this venture capitalist wants to harness the investing power of women
Stat
venture capital
biotech
startups
Women's Health
Flag link:
Biotech startup joins quest to harness microbiome to untether reliance on antibiotics in women's health
Biotech startup joins quest to harness microbiome to untether reliance on antibiotics in women's health
Endpoints
Luca Biologics
microbiome
Women's Health
vaginal microbiome
Flag link:
Apple recently hired a prominent obstetrician, signaling interest in women's health
Apple recently hired a prominent obstetrician, signaling interest in women's health
CNBC
Apple
Women's Health
Flag link:
Evotec and Ferring Team Up to Work on Women's Health Issues
Evotec and Ferring Team Up to Work on Women's Health Issues
CP Wire
Evotec
Ferring
small molecule drugs
Women's Health
Fertility
Flag link:
Allergan plans sales of women's health, infectious disease units
Allergan plans sales of women's health, infectious disease units
Reuters
Allergan
M&A
Women's Health
infectious diseases
Flag link:
Allergan toys with $5B women's health sale to boost bottom-feeding shares
Allergan toys with $5B women's health sale to boost bottom-feeding shares
Fierce Pharma
Allergan
Women's Health
M&A
Flag link:
Teva closes $703m sale of global women’s health biz to CVC Capital
Teva closes $703m sale of global women’s health biz to CVC Capital
Drug Delivery Business News
Teva Pharmaceutical
Women's Health
M&A
CVC Capital
Flag link:
Women’s health biotech KaNDy dickering with Allergan about a $400M buyout deal — report
Women’s health biotech KaNDy dickering with Allergan about a $400M buyout deal — report
Endpoints
Women's Health
KaNDy
Allergan
M&A
Flag link:
Allergan buys an ailing Repros, bagging a women’s health drug for the pipeline
Allergan buys an ailing Repros, bagging a women’s health drug for the pipeline
Endpoints
Allergan
Repros
M&A
Women's Health
Flag link:
Drug prices, the fate of Obamacare, and women’s health: How Alex Azar would shape HHS
Drug prices, the fate of Obamacare, and women’s health: How Alex Azar would shape HHS
Stat
drug pricing
Women's Health
Obamacare
healthcare reform
HHS
Alex Azar
Eli Lilly
Flag link:
Allergan could sell women's health for $6B, if it would only agree to split: analyst
Allergan could sell women's health for $6B, if it would only agree to split: analyst
Fierce Pharma
Allergan
Women's Health
M&A
Flag link:
Cash-strapped Teva closes in on women's health sale No. 2: report
Cash-strapped Teva closes in on women's health sale No. 2: report
Fierce Pharma
Teva Pharmaceutical
Women's Health
M&A
CVC
Flag link:
Bidders line up for Teva's women's health unit in potential $2B sale
Bidders line up for Teva's women's health unit in potential $2B sale
Fierce Pharma
Teva Pharmaceutical
M&A
Women's Health
Flag link:
Intas Pharmaceuticals offered $1.5bn for 3 divisions of Teva’s in Europe
Intas Pharmaceuticals offered $1.5bn for 3 divisions of Teva’s in Europe
GoInPharma
Intas
India
M&A
Teva Pharmaceutical
Europe
Women's Health
oncology
pain management
Flag link:
Teva sells as many as 4 assets: Medis, respiratory, women’s health and oncology
Teva sells as many as 4 assets: Medis, respiratory, women’s health and oncology
GoInPharma
Teva Pharmaceutical
M&A
Respiratory
Women's Health
oncology
Medis
Flag link:
Here's How Much Teva Pharmaceutical Could Net From the Sale of Non-Core Assets
Here's How Much Teva Pharmaceutical Could Net From the Sale of Non-Core Assets
Motley Fool
Teva Pharmaceutical
M&A
Women's Health
oncology
Flag link:
Teva, still searching for 'world-class' CEO, officially puts women's health, cancer on the block
Teva, still searching for 'world-class' CEO, officially puts women's health, cancer on the block
Fierce Pharma
Teva Pharmaceutical
Pharma CEOs
M&A
Women's Health
oncology
Flag link:
3 Reasons Teva Pharmaceutical Industries Lost Another $520 Million in Market Value in April
3 Reasons Teva Pharmaceutical Industries Lost Another $520 Million in Market Value in April
Fierce Pharma
Teva Pharmaceutical
bribery
Women's Health
oncology
reorganization
Flag link:
Debt-laden Teva, looking for cash, weighs $2B women's health sale: report
Debt-laden Teva, looking for cash, weighs $2B women's health sale: report
Fierce Pharma
Teva Pharmaceutical
M&A
Women's Health
Flag link:

Pages